Autism and the Brain Research
Return to Index | All research on one page
Ahlsen G, Rosengren L, Belfrage M, Palm A, Haglid K, Hamberger A, Gillberg C. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol Psychiatry. 1993 May 15;33(10):734-43.
Anderson MP, Hooker BS, Herbert MR. Bridging from Cells to Cognition in Autism Pathophysiology: Biological Pathways to Defective Brain Function and Plasticity. Am J Biochem Biotechnol 4(2): 167-176, 2008.
Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci 2005; 23:183-7.
Connor DF, Fletcher KE, Swanson JM.A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12):1551-9.
Corbett BA, Mendoza S, et al. Cortisol circadian rhythms and response to stress in children with autism. Psychoneuroendocrinology 2006: 31(1): 59-68.
Dennog C, Gedik C, Wood S, Speit G. Analysis of oxidative DNA damage and HPRT mutations in humans after hyperbaric oxygen treatment. Mutat Res. 1999 Dec 17;431(2):351-9.
Dufour F et al. Modulation of absence seizures by branched-chain amino acids: correlation with brain amino acid concentrations. Neurosci Res. 2001 Jul;40(3):255-63.
Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ. A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl). 2006 Oct 3.
Filipek PA, et al. (2000). Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 55(4): 468-79.
Friedman SD, Shaw DW, Artru AA, Richards TL, Gardner J, Dawson G, Posse S, Dager SR. Regional brain chemical alterations in young children with autism spectrum disorder. Neurology. 2003 Jan 14;60(1):100-7.
Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis. 2008 Jun;30(3):303-11.
Helms AK, Whelan HT, Torbey MT. Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovasc Dis. 2005;20(6):417-26.
Helt M, et al. Can children with autism recover? If so, how? Neuropsychol Rev. 2008 Dec;18(4):339-66.
Herbert M., Autism: A Brain disorder, or disorder that affects the brain? Clinical Neuropsychiatry 2006; 2:354-79.
Herbert MR. Large brains in autism: the challenge of pervasive abnormality. Neuroscientist 2005. 11(5): 417-40.
Hollander E, et al. Oxytocin Increases Retention of Social Cognition in Autism. Biol Psychiatry. 2006 Aug 10.
Hrdlicka M et al. Not EEG abnormalities but epilepsy is associated with autistic regression and mental functioning in childhood autism. Eur Child Adolesc Psychiatry. 2004 13(4):209-13.
Joiner, JT (Ed.). The Proceedings of the 2nd International Symposium on Hyperbaric Oxygenation for Cerebral Palsy and the Brain-Injured Child. Flagstaff, AZ: Best Publishing Company. (2002).
King BH, Bostic JQ. An update on pharmacologic treatments for autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):161-75.
López-Hurtado E, Prieto JJ. A microscopic study of language-related cortex in autism. Am J Biochem Biotechnol 2008: 4(2): 130. Lewine JD, et al. Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics. 1999 Sep;104(3 Pt 1):405-18.
MacFabe DF, et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007 Jan 10;176(1):149-69.
McCracken JT, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002 347(5): 314-21.
Mehler MF, Purpura DP. Autism, fever, epigenetics and the locus coeruleus. Brain Res Rev. 2008 Nov 24.
Ohnishi T, et al. Abnormal regional cerebral blood flow in childhood autism. Brain. 2000 Sep;123 ( Pt 9):1838-44.
Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathol 2007: 17(4): 434-47.
Park YD. The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau-Kleffner syndrome or autism. Epilepsy Behav. 2003 Jun;4(3):286-90.
Plioplys AV, Greaves A. Yoshida W. Anti-CNS antibodies in childhood neurologic diseases. Neuropediatrics. 1989;20:93.
Plioplys AV. Autism: electroencephalogram abnormalities and clinical improvement with valproic acid. Arch Pediatr Adolesc Med. 1994 Feb;148(2):220-2.
Posey DJ, Puntney JI, Sasher TM, Kem DL, McDougle CJ. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol. 2004 Summer;14(2):233-41.
Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007 Dec;38(6):276-81.
Rockswold GL, Ford SE, Anderson DC, Bergman TA, Sherman RE. Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg. 1992 Jun;76(6):929-34.
Rossignol DA, Rossignol LW. Hyperbaric oxygen therapy may improve symptoms in autistic children. Med Hypotheses. 2006;67(2):216-28.
Ryu YH, et al. Perfusion impairments in infantile autism on technetium-99m ethyl cysteinate dimer brain single-photon emission tomography: comparison with findings on magnetic resonance imaging. Eur J Nucl Med. 1999 Mar;26(3):253-9.
Sakoda M, Ueno S, Kihara K, Arikawa K, Dogomori H, Nuruki K, Takao S, Aikou T. A potential role of hyperbaric oxygen exposure through intestinal nuclear factor-kappaB. Crit Care Med. 2004 Aug;32(8):1722-9.
Shattock P, Kennedy A, Rowell F, Berney T. Role of neuropeptides in autism and their relationship with classical neurotransmitters. Brain Dysfunction 1990:3: 328-345.
Shultz SR, MacFabe DF, et al. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism. Neuropharmacology. 2008 May;54(6):901-11.
Tharp BR. Epileptic encephalopathies and their relationship to developmental disorders: Do spikes cause autism? Ment Retard Dev Disabil Res Rev. 2004;10(2):132-4.
Toda Y, Mori K, Hashimoto T, Miyazaki M, Nozaki S, Watanabe Y, Kuroda Y, Kagami S. Administration of secretin for autism alters dopamine metabolism in the central nervous system. Brain Dev. 2006 Mar;28(2):99-103.
Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005 Jan;57(1)67-81.
Wang XF, Cynader MS. Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem. 2000 74(4):1434-42.
Welch MG, Ludwig RJ, Opler M, Ruggiero DA. Secretin's role in the cerebellum: a larger biological context and implications for developmental disorders. Cerebellum. 2006;5(1):2-6.
Yang Z, Nandi J, Wang J, Bosco G, Gregory M, Chung C, Xie Y, Yang X, Camporesi EM. Hyperbaric oxygenation ameliorates indomethacin-induced enteropathy in rats by modulating TNF-alpha and IL-1beta production. Dig Dis Sci. 2006 Aug;51(8):1426.